Literature DB >> 365182

Past, present and future of the synthetic immunoadjuvant MDP and its analogs.

L Chedid, E Lederer.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 365182     DOI： 10.1016/0006-2952(78)90074-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  9 in total

1.  Formulation of vaccine adjuvant muramyldipeptides (MDP). 1. Characterization of amorphous and crystalline forms of a muramyldipeptide analogue.

Authors:  T W Chan; A Becker
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

2.  Synthesis and RES-stimulating activity of bacterial cell-wall peptidoglycan peptides related to FK-156.

Authors:  Y Kitaura; H Takeno; M Aratani; S Okada; S Yonishi; K Hemmi; O Nakaguchi; M Hashimoto
Journal:  Experientia       Date:  1982-09-15

3.  Structure-activity relationships in nucleotide oligomerization domain 1 (Nod1) agonistic γ-glutamyldiaminopimelic acid derivatives.

Authors:  Geetanjali Agnihotri; Rehman Ukani; Subbalakshmi S Malladi; Hemamali J Warshakoon; Rajalakshmi Balakrishna; Xinkun Wang; Sunil A David
Journal:  J Med Chem       Date:  2011-02-07       Impact factor: 7.446

4.  Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and in vivo.

Authors:  J Bouthillier; D Deblois; F Marceau
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

5.  Glucan-induced enhancement of host resistance to selected infectious diseases.

Authors:  J A Reynolds; M D Kastello; D G Harrington; C L Crabbs; C J Peters; J V Jemski; G H Scott; N R Di Luzio
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

6.  Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice.

Authors:  K Matsumoto; H Ogawa; T Kusama; O Nagase; N Sawaki; M Inage; S Kusumoto; T Shiba; I Azuma
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

7.  Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.

Authors:  M A Parant; F M Audibert; L A Chedid; M R Level; P L Lefrancier; J P Choay; E Lederer
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

8.  Adjuvant activity of a novel metabolizable lipid emulsion with inactivated viral vaccines.

Authors:  J A Reynolds; D G Harrington; C L Crabbs; C J Peters; N R Di Luzio
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

9.  Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure.

Authors:  K M Kengatharan; S De Kimpe; C Robson; S J Foster; C Thiemermann
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.